Kanada - İngilizce - Health Canada

tillotts pharma ag - mesalazine - tablet (delayed-release) - 800mg - mesalazine 800mg - anti-inflammatory agents

Kanada - İngilizce - Health Canada

tillotts pharma ag - mesalazine - tablet (delayed-release) - 1600mg - mesalazine 1600mg

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

pharmacia laboratories limited - sulfasalazine - suppositories - 500 milligram

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

rosemont pharmaceuticals ltd - sulfasalazine - oral suspension - 250 mg/5ml

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

rosemont pharmaceuticals ltd - sulfasalazine - oral suspension - 250 mg/5ml

Japonya - İngilizce - すりの適正使用協議会 RAD-AR Council, Japan

pfizer pharmaceuticals inc. - salazosulfapyridine - yellowish brown to brownish-red spindle-shaped suppository, diameter: 8 to 11 mm, length: 30 mm

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

apotex nz ltd - cilazapril monohydrate 5.22mg equivalent to 5 mg cilazapril base; hydrochlorothiazide 12.5mg - film coated tablet - 5 mg/12.5 mg - active: cilazapril monohydrate 5.22mg equivalent to 5 mg cilazapril base hydrochlorothiazide 12.5mg excipient: hyprolose hypromellose iron oxide red macrogol 8000 maize starch microcrystalline cellulose sodium stearyl fumarate titanium dioxide - apo-cilazapril/hctz is indicated for the treatment of patients with hypertension who are not adequately controlled on monotherapy.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

pharmacia biosystems limited - sulfasalazine - oral suspension - 250 mg/5ml

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

pharmacia laboratories limited - sulfasalazine - rectal solution - 30 mg/ml

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - sulfasalazine 3% - enema - 3 % - active: sulfasalazine 3%